Boey, L.; Bosmans, E.; Ferreira, L.B.; Heyvaert, N.; Nelen, M.; Smans, L.; Tuerlinckx, H.; Roelants, M.; Claes, K.; Derdelinckx, I.;
et al. Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients. Vaccines 2021, 9, 18.
https://doi.org/10.3390/vaccines9010018
AMA Style
Boey L, Bosmans E, Ferreira LB, Heyvaert N, Nelen M, Smans L, Tuerlinckx H, Roelants M, Claes K, Derdelinckx I,
et al. Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients. Vaccines. 2021; 9(1):18.
https://doi.org/10.3390/vaccines9010018
Chicago/Turabian Style
Boey, Lise, Eline Bosmans, Liane Braz Ferreira, Nathalie Heyvaert, Melissa Nelen, Lisa Smans, Hanne Tuerlinckx, Mathieu Roelants, Kathleen Claes, Inge Derdelinckx,
and et al. 2021. "Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients" Vaccines 9, no. 1: 18.
https://doi.org/10.3390/vaccines9010018
APA Style
Boey, L., Bosmans, E., Ferreira, L. B., Heyvaert, N., Nelen, M., Smans, L., Tuerlinckx, H., Roelants, M., Claes, K., Derdelinckx, I., Janssens, W., Mathieu, C., Van Cleemput, J., Vos, R., Desombere, I., & Vandermeulen, C.
(2021). Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients. Vaccines, 9(1), 18.
https://doi.org/10.3390/vaccines9010018
